Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127750921 | 12775092 | 1 | I | 20130621 | 20150814 | 20160923 | 20160923 | PER | US-PFIZER INC-2978313 | PFIZER | 61.00 | YR | F | Y | 53.70000 | KG | 20160923 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127750921 | 12775092 | 1 | PS | CARBOPLATIN. | CARBOPLATIN | 1 | U | UNK | 76517 | SOLUTION FOR INJECTION | |||||||||
| 127750921 | 12775092 | 2 | SS | DOCETAXEL. | DOCETAXEL | 1 | Intravenous (not otherwise specified) | UNK | Y | UNK | 22234 | SOLUTION FOR INJECTION | |||||||
| 127750921 | 12775092 | 3 | SS | TAXOL | PACLITAXEL | 1 | Intravenous (not otherwise specified) | UNK | Y | UNK | 0 | ||||||||
| 127750921 | 12775092 | 4 | SS | LIPOSOMAL DOXORUBICIN HYDROCHLORIDE | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | UNK | Y | UNK | 0 | ||||||||
| 127750921 | 12775092 | 5 | C | EVEROLIMUS | EVEROLIMUS | 1 | UNK | 0 | |||||||||||
| 127750921 | 12775092 | 6 | C | EXEMESTANE. | EXEMESTANE | 1 | UNK | 0 | |||||||||||
| 127750921 | 12775092 | 7 | C | LOPERAMIDE | LOPERAMIDE | 1 | FREQ: AS NEEDED | 0 | |||||||||||
| 127750921 | 12775092 | 8 | C | ONDANSETRON | ONDANSETRON | 1 | 8 MG, PM, FREQ: 3 DAY; INTERVAL: 1 | 0 | 8 | MG | |||||||||
| 127750921 | 12775092 | 9 | C | SENNA /00142201/ | SENNA LEAF | 1 | FREQ: AS NEEDED | 0 | |||||||||||
| 127750921 | 12775092 | 10 | C | VITAMIN D /00107901/ | ERGOCALCIFEROL | 1 | 1000 IU, FREQ: 1 DAY; INTERVAL: 1 | 0 | 1000 | IU |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127750921 | 12775092 | 1 | Breast cancer metastatic |
| 127750921 | 12775092 | 2 | Breast cancer metastatic |
| 127750921 | 12775092 | 3 | Breast cancer metastatic |
| 127750921 | 12775092 | 4 | Breast cancer metastatic |
| 127750921 | 12775092 | 5 | Breast cancer metastatic |
| 127750921 | 12775092 | 6 | Breast cancer metastatic |
| 127750921 | 12775092 | 7 | Product used for unknown indication |
| 127750921 | 12775092 | 8 | Product used for unknown indication |
| 127750921 | 12775092 | 9 | Product used for unknown indication |
| 127750921 | 12775092 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127750921 | 12775092 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127750921 | 12775092 | Drug intolerance | |
| 127750921 | 12775092 | Hypersensitivity | |
| 127750921 | 12775092 | Infusion related reaction | |
| 127750921 | 12775092 | Neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127750921 | 12775092 | 2 | 20130101 | 20130101 | 0 | |
| 127750921 | 12775092 | 3 | 20130101 | 20130626 | 0 | |
| 127750921 | 12775092 | 4 | 20130101 | 20130101 | 0 | |
| 127750921 | 12775092 | 5 | 20150301 | 0 | ||
| 127750921 | 12775092 | 6 | 20150301 | 0 |